282 results match your criteria: "Department of Clinical Research and Development[Affiliation]"

Key considerations regarding veno-arterial extracorporeal membrane oxygenation for the treatment of cardiogenic shock and cardiac arrest - Letter to Son et al.

Intensive Crit Care Nurs

February 2025

Department of Clinical Research and Development, LUXMED Group, Warsaw, Poland; Institute of Outcomes Research, Maria Sklodowska-Curie Medical Academy, Warsaw, Poland; Henry JN Taub Department of Emergency Medicine, Baylor College of Medicine, Houston, TX, USA. Electronic address: Lukasz.szarpak@gmai

View Article and Find Full Text PDF

Adverse events associated with early initiation of Eplerenone in patients hospitalized for acute heart failure.

Int J Cardiol

November 2024

Cardiovascular Research and Development Center, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Porto, Portugal; Heart Failure Clinic, Internal Medicine Department, Centro Hospitalar de Vila Nova de Gaia/Espinho, Gaia, Portugal; Université de Lorraine, INSERM,

Article Synopsis
  • The HEART study examined the effects of eplerenone, a mineralocorticoid receptor antagonist, in patients hospitalized for acute heart failure (HF) over 6 months, highlighting concerns about potential adverse events like worsening renal function and hyperkalemia.
  • Among 297 participants, notable adverse events were recorded, but eplerenone did not significantly raise their occurrence compared to placebo, suggesting it is a safe option for HF treatment.
  • Certain patient characteristics, such as older age and existing health conditions, were linked to a higher risk of adverse events, but these factors did not diminish the benefits of eplerenone on overall outcomes.
View Article and Find Full Text PDF

The gray-white matter ratio in adult out-of-hospital cardiac arrest patients must be assessed comprehensively.

Resuscitation

October 2024

Department of Clinical Research and Development, LUXMED Group, Warsaw, Poland; Institute of Outcomes Research, Maria Sklodowska-Curie Medical Academy, Warsaw, Poland; Henry JN Taub Department of Emergency Medicine, Baylor College of Medicine, Houston, TX, USA. Electronic address: Lukasz.szarpak@gmai

View Article and Find Full Text PDF

The prediction of alterations in plasma sodium levels in acutely ill patients should be more comprehensive.

Eur J Intern Med

January 2025

Department of Clinical Research and Development, LUXMED Group, Warsaw, , Poland; Institute of Outcomes Research, Maria Sklodowska-Curie Medical Academy, Warsaw, , Poland; Henry JN Taub Department of Emergency Medicine, Baylor College of Medicine, Houston, TX, USA. Electronic address: Lukasz.szarpak@

View Article and Find Full Text PDF

The Effect of Thickened Water on Ciprofloxacin Pharmacokinetics: A Comparative Study in Adult Males.

J Clin Med

August 2024

Department of Clinical Research and Development, Graduate School of Pharmacy, Showa University, Tokyo 157-8577, Japan.

Article Synopsis
  • The use of food thickeners with ciprofloxacin can alter the drug’s appearance and slow down its dissolution, potentially affecting its effectiveness and posing economic concerns in healthcare.
  • A study was conducted on healthy Japanese males to compare how different methods of taking ciprofloxacin (with water, thickened water, and crushed tablets in thickened water) affect drug absorption.
  • Results showed that while thickened water changed drug absorption, crushed tablets in thickened water provided similar absorption metrics as tablets with regular water, though crushing may risk losing active ingredients and requires careful consideration.
View Article and Find Full Text PDF

We investigated the potential diagnostic role of galectin-3 (Gal-3) in patients presenting with suspected acute coronary syndromes (ACS). We searched PubMed Central, Scopus, EMBASE, and the Cochrane Library from inception until 20 June 2024. We measured effect sizes using odds ratios (OR) with 95% CIs for dichotomous data and mean differences (MD) with CIs for continuous data.

View Article and Find Full Text PDF

Long-term inhaled corticosteroid treatment in patients with chronic obstructive lung disease, cardiovascular disease, and recent hospitalization for exacerbation.

Eur J Intern Med

November 2024

Department of Clinical Research and Development, LUXMED Group, Warsaw, Poland; Institute of Outcomes Research, Maria Sklodowska-Curie Medical Academy, Warsaw, Poland; Henry JN Taub Department of Emergency Medicine, Baylor College of Medicine, Houston, TX, USA. Electronic address: Lukasz.szarpak@gmai

View Article and Find Full Text PDF

VISCERAL SENSITIVITY INDEX (VSI-IT): Italian Adaptation and Validation.

Eur J Investig Health Psychol Educ

July 2024

Post-Graduate School of Occupational Medicine, Faculty of Medicine and Surgery, Catholic University of the Sacred Heart, 00168 Rome, Italy.

Article Synopsis
  • * A study tested the Italian VSI on 500 participants, including patients with Crohn's disease, ulcerative colitis, IBS, and healthy controls, ensuring accurate translation and implementation through an online survey.
  • * The results showed that the Italian VSI is reliable and valid, effectively identifying differences in sensitivity and correlating with symptoms, thus aiding in better understanding and treatment of gastrointestinal disorders in Italy.
View Article and Find Full Text PDF

Current evidence suggests that airborne pollutants have a detrimental effect on fetal growth through the emergence of small for gestational age (SGA) or term low birth weight (TLBW). The study's objective was to critically evaluate the available literature on the association between environmental pollution and the incidence of SGA or TLBW occurrence. A comprehensive literature search was conducted across Pubmed/MEDLINE, Web of Science, Cochrane Library, EMBASE, and Google Scholar using predefined inclusion and exclusion criteria.

View Article and Find Full Text PDF

Tunlametinib (HL-085) plus vemurafenib in patients with advanced BRAF V600-mutant solid tumors: an open-label, single-arm, multicenter, phase I study.

Exp Hematol Oncol

June 2024

Clinical Pharmacology Research Center, State Key Laboratory of Complex Severe and Rare Diseases, NMPA Key Laboratory for Clinical Research and Evaluation of Drug, Beijing Key Laboratory of Clinical PK and PD Investigation for Innovative Drugs, Peking Union Medical College Hospital, Chinese Academy o

Article Synopsis
  • Tunlametinib (HL-085) is a new MEK inhibitor that shows promise for treating patients with NRAS-mutant melanoma and was tested in combination with vemurafenib for patients with advanced BRAF V600-mutant solid tumors.
  • In the phase I trial involving 72 patients, there were no significant safety issues, and the recommended dose for future studies was established as 9 mg of tunlametinib with 720 mg of vemurafenib, administered twice daily.
  • Results showed a 60.6% objective response rate for non-small cell lung cancer patients, with a median progression-free survival of 10.5 months, although treatment-related adverse events were common, especially anemia and increased blood
View Article and Find Full Text PDF

Ultrasound-guided fine-needle aspiration is the standard for evaluating thyroid nodules with a high safety profile and a relatively low number of non-diagnostic cytological findings. Nevertheless, this diagnostic method traditionally has its weak points. Several diagnostic categories such as Bethesda I, III and IV are not reliable for thyroid carcinoma risk assessment.

View Article and Find Full Text PDF

Objective: SHR-1703 is a novel humanized IgG1 monoclonal antibody with high IL-5 affinity and prolonged half-life, aiming to control eosinophil-related diseases. The study intended to evaluate pharmacokinetics, pharmacodynamics, immunogenicity, safety, and tolerability of SHR-1703 in healthy subjects.

Methods: A single-center, randomized, double-blind, placebo-controlled, single-dose escalation phase I study was conducted.

View Article and Find Full Text PDF
Article Synopsis
  • Differentiating between sex and gender is essential in the biomedical field, particularly in orthopedics, to improve understanding of musculoskeletal conditions and personalize treatments.
  • The review emphasizes how hormonal differences affect the structure and function of bones and other tissues, with specific examples illustrating the distinct orthopedic issues faced by different sexes, such as higher rates of certain deformities and osteoporosis in women.
  • It calls for improved research practices to include sex and gender disaggregation and to acknowledge the needs of sexual minority and gender-diverse individuals in orthopedic care for better health outcomes.
View Article and Find Full Text PDF
Article Synopsis
  • A study analyzed urinary microRNAs in patients with esophageal squamous cell carcinoma (ESCC) to find potential biomarkers for monitoring tumor burden during treatment.
  • Researchers compared microRNA expressions among patients who underwent different treatments (esophagectomy and endoscopic submucosal resection) and healthy individuals to identify significant differences.
  • Out of 205 selected microRNAs, 18 showed consistent changes related to tumor burden and 3 of these indicated a trend with tumor recurrence, suggesting they could be useful for tracking ESCC progression and treatment response.
View Article and Find Full Text PDF

Background: Recent large clinical trials have revealed that sodium-glucose cotransporter 2 (SGLT2) inhibitors improve cardiovascular outcomes not only in patients with heart failure with reduced ejection fraction, but also in patients with heart failure with mildly reduced or preserved ejection fraction (HFpEF). However, the effect of SGLT2 inhibitors on left ventricular (LV) diastolic function is still controversial.

Methods And Results: The TOP-HFPEF trial (Efficacy of Tofogliflozin on Left Ventricular Diastolic Dysfunction in Patients with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes Mellitus) is a multicenter, double-arm, open-label, confirmatory, investigator-initiated clinical study to investigate the effect of SGLT2 inhibitor on LV diastolic function in patients with HFpEF and type 2 diabetes mellitus.

View Article and Find Full Text PDF

sp. nov., isolated from faeces of heart failure mouse model.

Int J Syst Evol Microbiol

May 2024

Department of Infection Metagenomics, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.

Article Synopsis
  • Strain TC023 is a new species of Gram-positive, anaerobic bacteria discovered in a heart failure mouse model, characterized by its long, rod shape and spore-forming ability.
  • It formed distinct greyish-white colonies on a specific growth medium and showed close genetic similarities to existing strains MMM721 and MOL361 based on 16S rRNA gene sequencing.
  • Genomic analysis revealed that TC023 has unique DNA characteristics, leading to its classification as a novel species within its genus, with TC023 designated as the type strain.
View Article and Find Full Text PDF

Does the SVEAT score truly represent the future of risk stratification for acute chest pain?

Am J Emerg Med

June 2024

Department of Clinical Research and Development, LUXMED Group, Warsaw, Poland; Henry JN Taub Department of Emergency Medicine, Baylor College of Medicine, Houston, TX 77030, USA.

View Article and Find Full Text PDF